ArticleBMC nursing2026
The effect of remote nurse-led patient education and follow-up on glycemic control and metabolic function in patients with type 2 diabetes: a single-blind randomized controlled trial.
Article in BMC nursing, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND &
objectiveType 2 Diabetes (T2D) is a chronic metabolic disorder characterized by impaired insulin secretion, insulin resistance, and progressive β-cell dysfunction that ultimately leads to serious vascular and metabolic complications. Effective diabetes management requires innovative approaches such as remote education and nurse-led interventions. Therefore, this study aimed to investigate the effect of remote nurse-led patient education and follow-up on glycemic control and key metabolic functions including pancreatic β-cell function (HOMA-β), insulin sensitivity (HOMA-α), and insulin resistance (HOMA-IR) in T2D patients. METHODS & MATERIALS: This is a single-blind randomized controlled trial conducted on a total of 66 patients with T2D. Participants were randomly assigned to the intervention (n = 33) and control (n = 33) groups. The intervention group received three months of daily remote education via text, audio, and video messages combined with weekly follow-ups. Baseline and post-intervention data included Fasting Blood Glucose (FBG), fasting insulin, glycosylated hemoglobin (HbA1c), and HOMA indices. Data were analyzed using IBM SPSS Statistics for Windows, version 22 (IBM Corp., Armonk, N.Y., USA).
resultsSignificant within-group improvements were observed in the intervention group for FBG, HbA1c, HOMA-β, HOMA-α, and HOMA-IR scores (p < 0.05); however, the control group showed no significant within-group changes (p > 0.05). Between-group analysis showed greater improvements in the intervention group compared to the control group for all above outcomes (p < 0.05).
conclusionIn this randomized trial, a three-month remote nurse-led patient education and follow-up program was associated with improvements in several glycemic and metabolic markers, including FBG, HbA1c, HOMA-IR, HOMA-α, and HOMA-β, compared with usual care. These preliminary findings suggest potential metabolic benefits and highlight the need for larger, longer-term studies to confirm these effects before broader clinical application.
trial registrationThis study was prospectively registered in the Iranian Registry of Clinical Trials on 15 July 2024 (IRCT20240708062366N1, https://irct.behdasht.gov.ir/trial/77809 ). After trial registration, participant recruitment began on 1 August 2024 and continued until 1 October 2024.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.